Abstract
Lysyl hydroxylase 2 (LH2) is a member of LH family that catalyzes the hydroxylation of lysine (Lys) residues on collagen, and this particular isozyme has been implicated in various diseases. While its function as a telopeptidyl LH is generally accepted, several fundamental questions remain unanswered: 1. Does LH2 catalyze the hydroxylation of all telopeptidyl Lys residues of collagen? 2. Is LH2 involved in the helical Lys hydroxylation? 3. What are the functional consequences when LH2 is completely absent? To answer these questions, we generated LH2-null MC3T3 cells (LH2KO), and extensively characterized the type I collagen phenotypes in comparison with controls. Cross-link analysis demonstrated that the hydroxylysine-aldehyde (Hylald)-derived cross-links were completely absent from LH2KO collagen with concomitant increases in the Lysald-derived cross-links. Mass spectrometric analysis revealed that, in LH2KO type I collagen, telopeptidyl Lys hydroxylation was completely abolished at all sites while helical Lys hydroxylation was slightly diminished in a site-specific manner. Moreover, di-glycosylated Hyl was diminished at the expense of mono-glycosylated Hyl. LH2KO collagen was highly soluble and digestible, fibril diameters were diminished, and mineralization impaired when compared to controls. Together, these data underscore the critical role of LH2-catalyzed collagen modifications in collagen stability, organization and mineralization in MC3T3 cells.
Original language | English |
---|---|
Article number | 14256 |
Journal | Scientific Reports |
Volume | 12 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2022 |
Bibliographical note
Publisher Copyright:© 2022, The Author(s).
Funding
This work was supported by NIH R01CA251067 and SPORE P50CA070907 to JMK and MY, Basic Science Fund from Nippi to YT, JSPS KAKENHI Grant Number JP19H03439 to TN, NIH R01 HL049277 to NMS, Developmental Research Program Grant from the Yale Head and Neck SPORE NIDCR P50-DE030707 to ALA, NIH R00 CA225633 to HG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funders | Funder number |
---|---|
Office of Research Infrastructure Programs, National Institutes of Health | |
National Institutes of Health (NIH) | |
National Heart, Lung, and Blood Institute (NHLBI) | R01HL049277 |
National Institute of Dental and Craniofacial Research | P50DE030707 |
Japan Society for the Promotion of Science | P50-DE030707, R00 CA225633, R01 HL049277, JP19H03439, 23K24098 |
National Childhood Cancer Registry – National Cancer Institute | R01CA251067, P50CA070907, R00CA225633 |
National Institute of General Medical Sciences | P20GM121327 |
ASJC Scopus subject areas
- General